Clinical trial
Safety of SPD465 in Treating Adults With ADHD.
NCT00152035 · Shire, Industry · Completed
Key facts
| NCT number | NCT00152035 |
|---|---|
| Title | Safety of SPD465 in Treating Adults With ADHD. |
| Official title | A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD). |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug |
| Interventions | Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate. |
| Enrollment | 505 |
| Start date | Mar 10, 2005 |
| Primary completion | Nov 7, 2006 |
| Completion | Nov 7, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Aug 23, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: